Rolta India is currently trading at Rs. 115.50, up by 5.60 points or 5.10% from its previous closing of Rs. 109.90 on the BSE.
The scrip opened at Rs. 111.10 and has touched a high and low of Rs. 116.60 and Rs. 110.20 respectively. So far 745430 shares were traded on the counter.
The BSE group 'B' stock of face value Rs. 10 has touched a 52 week high of Rs. 121.80 on 07-Jul-2014 and a 52 week low of Rs. 53.00 on 02-Aug-2013.
Last one week high and low of the scrip stood at Rs. 116.60 and Rs. 103.50 respectively. The current market cap of the company is Rs. 1786.72 crore.
The promoters holding in the company stood at 50.54% while Institutions and Non-Institutions held 19.26% and 29.19% respectively.
Rolta has been awarded an additional scope of work by Sadara Chemical Company (Sadara) to implement a comprehensive Engineering information System within Sadara's Jubail integrated chemical complex. This multi-million dollar award of additional scope is an amendment to the contract which was awarded earlier and which was also multi-million dollars in value. Rolta was selected for this challenging project based on its unique combination of world class capabilities in Engineering and Information Technology (IT). The project is being managed by a global Rolta team working out of the United States, India and Saudi Arabia.
Rolta has been leveraging its in-depth knowledge of engineering work processes, application systems, IT and systems integration to provide an extensive suite of engineering solutions designed to support Process Engineering, Technical Support, Process Automation and Control, Asset Integrity, Analytical Lab and Standards, and Document Management.
Rolta India conducts business in India, and internationally through subsidiaries in various countries. Rolta is a leading provider of innovative IT solutions built around its intellectual property for many vertical segments, including Federal and State Governments, Defence, Homeland Security, Utilities, Process, Power, Financial Services, Manufacturing, Retail, and Healthcare.
| Company Name | CMP |
|---|---|
| TCS | 2397.30 |
| Infosys | 1154.45 |
| HCL Tech. | 1203.25 |
| Wipro | 199.40 |
| Tech Mahindra | 1360.05 |
| View more.. | |
MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.
To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.
MoneyWorks4Me ensures this through: